Literature DB >> 15946126

Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters.

Matthew J Harris1, David G Le Couteur, Irwin M Arias.   

Abstract

Progressive familial intrahepatic cholestasis types 1, 2 and 3 are childhood diseases of the liver. Benign recurrent intrahepatic cholestasis is predominantly an adult form with similar clinical symptoms that spontaneously resolve. These genetic disorders have significantly helped to unravel the basic mechanisms of the canalicular bile transport processes. Progressive familial intrahepatic cholestasis type 1 involves a gene also linked to benign recurrent intrahepatic cholestasis. The gene codes for an aminophospholipid translocase protein that maintains the integrity of the membrane. How a mutation in this protein causes cholestasis is unknown but is thought to involve the enterohepatic recirculation of bile acids. Progressive familial intrahepatic cholestasis types 2 and 3 involve the canalicular bile salt export pump and a phospholipid translocase, respectively, both of which are fundamental to bile secretion. This review covers the clinical manifestations, genetics, treatment and mechanism of each disease. (c) 2005 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946126     DOI: 10.1111/j.1440-1746.2005.03743.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.

Authors:  Yannick Beauséjour; Fernando Alvarez; Martin Beaulieu; Marc Bilodeau
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

Review 2.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

3.  Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis.

Authors:  Ji Sook Park; Jae Sung Ko; Jeong Kee Seo; Jin Soo Moon; Sung Sup Park
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

4.  A new ABCB11 mutation in two Italian children with familial intrahepatic cholestasis.

Authors:  Valerio Nobili; Silvia Di Giandomenico; Paola Francalanci; Francesco Callea; Matilde Marcellini; Filippo M Santorelli
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

5.  Novel ABCB11 mutations in a Thai infant with progressive familial intrahepatic cholestasis.

Authors:  Suporn Treepongkaruna; Amornphun Gaensan; Paneeya Pienvichit; Ondrej Luksan; A S Knisely; Pattana Sornmayura; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

6.  miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity.

Authors:  Ryan M Allen; Tyler J Marquart; Carolyn J Albert; Frederick J Suchy; David Q-H Wang; Meenakshisundaram Ananthanarayanan; David A Ford; Angel Baldán
Journal:  EMBO Mol Med       Date:  2012-07-05       Impact factor: 12.137

7.  A novel ABCB11 mutation in an Iranian girl with progressive familial intrahepatic cholestasis.

Authors:  Sassan Saber; Reza Vazifehmand; Iman Bagherizadeh; Mahbubeh Kasiri
Journal:  Indian J Hum Genet       Date:  2013-07

8.  Diagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing.

Authors:  Guorui Hu; Ping He; Zhifeng Liu; Qian Chen; Bixia Zheng; Qihua Zhang
Journal:  Mol Med Rep       Date:  2014-06-20       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.